Researchers use nanoparticles to target brain cancer cells

08/20/2009 | HealthImaging.com

Researchers attached titanium dioxide nanoparticles to biomolecules to be able to therapeutically target brain cancer cells without harming normal tissue. Tests have been conducted on preclinical lab models of brain tumors, and animal studies are being planned next. "Results show an almost 100 percent cancer cell toxicity rate after six hours of illumination and 80 percent after 48 hours," the researchers said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations